{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:38:17Z","timestamp":1792165097569,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.endien.2023.12.001","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T09:13:53Z","timestamp":1711530833000},"page":"83-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of semaglutide on weight loss and glycaemic control in patients with Prader\u2013Willi Syndrome and type 2 diabetes"],"prefix":"10.1016","volume":"71","author":[{"given":"Olga","family":"Gim\u00e9nez-Palop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Casamitjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Rigla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assumpta","family":"Caix\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endien.2023.12.001_bib0115","first-page":"10","article-title":"Prader\u2013Willi Syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med Off J Am Coll Med Genet"},{"key":"10.1016\/j.endien.2023.12.001_bib0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader\u2013Willi Syndrome \u2013 clinical genetics diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/j.endien.2023.12.001_bib0125","first-page":"229","article-title":"Treatment with growth hormone in the Prader\u2013Willi Syndrome","volume":"65","author":"Moix","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/j.endien.2023.12.001_bib0130","first-page":"579","article-title":"Psychopathological disorders in Prader\u2013Willi Syndrome","volume":"66","author":"Guinovart","year":"2019","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/j.endien.2023.12.001_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-020-1284-5","article-title":"Update on diabetes mellitus and glucose metabolism alterations in Prader\u2013Willi syndrome","volume":"20","author":"Crin\u00f2","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.endien.2023.12.001_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","article-title":"Endocrine disorders in children with Prader\u2013Willi Syndrome \u2013 data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.endien.2023.12.001_bib0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ajmg.a.32133","article-title":"The Italian National Survey for Prader\u2013Willi Syndrome: an epidemiologic study","volume":"146A","author":"Grugni","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.endien.2023.12.001_bib0150","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ajmg.a.34171","article-title":"Physical health problems in adults with Prader\u2013Willi Syndrome","volume":"155A","author":"Sinnema","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.endien.2023.12.001_bib0155","doi-asserted-by":"crossref","first-page":"e12992","DOI":"10.1111\/obr.12992","article-title":"Current and emerging therapies for managing hyperphagia and obesity in Prader\u2013Willi Syndrome: a narrative review","volume":"21","author":"Tan","year":"2020","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"10.1016\/j.endien.2023.12.001_bib0160","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4239\/wjd.v7.i20.572","article-title":"Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity","volume":"7","author":"Anandhakrishnan","year":"2016","journal-title":"World J Diabetes"},{"key":"10.1016\/j.endien.2023.12.001_bib0165","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1517\/14656566.8.15.2593","article-title":"Exenatide","volume":"8","author":"Barnett","year":"2007","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.endien.2023.12.001_bib0170","series-title":"FDA approves Saxenda for the treatment of obesity in adolescents aged 12\u201317","author":"Nordisk","year":"2020"},{"key":"10.1016\/j.endien.2023.12.001_bib0175","unstructured":"Nordisk N. EMA approves liraglutide for teenagers with obesity. https:\/\/diabetes.medicinematters.com\/liraglutide--obesity-\/adolescents\/."},{"key":"10.1016\/j.endien.2023.12.001_bib0180","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1530\/EJE-12-0997","article-title":"GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases","volume":"168","author":"Zoicas","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endien.2023.12.001_bib0185","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.endien.2023.12.001_bib0190","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.endien.2023.12.001_bib0195","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1507\/endocrj.EJ12-0074","article-title":"The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader\u2013Willi Syndrome","volume":"59","author":"Senda","year":"2012","journal-title":"Endocr J"},{"key":"10.1016\/j.endien.2023.12.001_bib0200","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/clinem\/dgac549","article-title":"Liraglutide for weight management in children and adolescents with Prader\u2013Willi syndrome and obesity","volume":"108","author":"Diene","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endien.2023.12.001_bib0205","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.3390\/jcm10194540","article-title":"Anti-obesity medication use in children and adolescents with Prader\u2013Willi syndrome: case review and literature search","volume":"10","author":"Goldman","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.endien.2023.12.001_bib0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cen.14583","article-title":"The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader\u2013Willi Syndrome: a systematic review","volume":"96","author":"Ng","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endien.2023.12.001_bib0215","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2174\/1871530322666220509225637","article-title":"Effects of semaglutide on glycemic control and weight loss in a patient with Prader\u2013Willi syndrome: a case report","volume":"22","author":"Sani","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.endien.2023.12.001_bib0220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s43856-023-00359-w","article-title":"Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT-2-inhibitors: a systematic review","volume":"3","author":"Young","year":"2023","journal-title":"Commun Med (Lond)"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530018024000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T21:51:40Z","timestamp":1711576300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530018024000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2530018024000222"],"URL":"https:\/\/doi.org\/10.1016\/j.endien.2023.12.001","relation":{},"ISSN":["2530-0180"],"issn-type":[{"value":"2530-0180","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of semaglutide on weight loss and glycaemic control in patients with Prader\u2013Willi Syndrome and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endien.2023.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEEN and SED.","name":"copyright","label":"Copyright"}]}}